MetLife Investment Management’s Covanta Holding Corporation CVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-41,605
Closed -$837K 2601
2021
Q3
$837K Buy
41,605
+3,714
+10% +$73.4K 0.01% 1218
2021
Q2
$667K Sell
37,891
-6,669
-15% -$101K 0.01% 1404
2021
Q1
$618K Buy
44,560
+4,394
+11% +$62.8K 0.01% 1401
2020
Q4
$527K Sell
40,166
-8,159
-17% -$88.2K 0.01% 1467
2020
Q3
$375K Sell
48,325
-9,013
-16% -$82.7K ﹤0.01% 1523
2020
Q2
$550K Buy
57,338
+10,007
+21% +$85.6K 0.01% 1327
2020
Q1
$405K Hold
47,331
0.01% 1323
2019
Q4
$702K Sell
47,331
-6,573
-12% -$100K 0.01% 1274
2019
Q3
$932K Hold
53,904
0.01% 1106
2019
Q2
$965K Hold
53,904
0.01% 1120
2019
Q1
$933K Hold
53,904
0.01% 1110
2018
Q4
$723K Hold
53,904
0.01% 1159
2018
Q3
$876K Hold
53,904
0.01% 1201
2018
Q2
$889K Buy
53,904
+5,710
+12% +$89.9K 0.01% 1071
2018
Q1
$699K Sell
48,194
-7,027
-13% -$111K 0.01% 1170
2017
Q4
$933K Buy
+55,221
New +$853K 0.01% 1055

Other funds holding CVA

MetLife Investment Management's CVA Position: Q4 2021 in Review

MetLife Investment Management sold out of Covanta Holding Corporation (CVA) in Q4 2021, closing a stake of 41,605 shares — an estimated $837K sold.

MetLife Investment Management first reported a position in CVA in Q4 2017 and held it in 16 quarters. The position peaked at $965K in Q2 2019. 2 funds tracked by Wall St. Rank hold CVA as of Q4 2021.

  • MetLife Investment Management reported no remaining Covanta Holding Corporation position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 41,605 Covanta Holding Corporation shares in Q4 2021, an estimated $837K.
  • MetLife Investment Management first reported a position in Covanta Holding Corporation in Q4 2017 and held it in 16 quarters.
  • MetLife Investment Management's Covanta Holding Corporation position peaked at $965K in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Covanta Holding Corporation as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.